tiprankstipranks
Trending News
More News >
Cymbria Corp Cl A NV (TSE:CYB)
TSX:CYB

Cymbria Corp Cl A (CYB) AI Stock Analysis

Compare
12 Followers

Top Page

TSE:CYB

Cymbria Corp Cl A

(TSX:CYB)

Select Model
Select Model
Select Model
Outperform 76 (OpenAI - 5.2)
Rating:76Outperform
Price Target:
C$108.00
▲(20.81% Upside)
Action:UpgradedDate:12/30/25
The score is driven primarily by strong profitability and a very conservative balance sheet, partially offset by weaker cash-flow conversion versus earnings and historical variability in cash generation. Valuation is supportive due to a low P/E, while technical indicators suggest a neutral-to-mildly positive trend rather than a strong momentum setup.
Positive Factors
Conservative balance sheet / low leverage
Extremely low leverage and a large equity base provide durable financial flexibility. This supports the fund’s ability to absorb market drawdowns, maintain policy decisions like distributions or opportunistic purchases, and reduces refinancing risk over multi‑quarter horizons.
Strong recent profitability and profit conversion
Very high profit conversion and improved TTM results underpin internal capital generation, enabling reinvestment and potential payouts without relying solely on asset sales. Sustained earnings strength supports NAV growth and strategic allocations over the medium term.
Low market sensitivity (low beta)
A low beta indicates the portfolio exhibits lower systematic volatility versus the market. For a closed‑end investment vehicle, this can translate to steadier NAV fluctuations, reduced downside in market stress, and a more predictable capital base for multi‑quarter planning.
Negative Factors
Weak cash flow conversion versus earnings
Low conversion of reported earnings to cash limits internally available liquidity for distributions, buybacks, or new investments without realizing holdings. Over several quarters this increases reliance on asset sales, potentially forcing timing‑sensitive decisions that hurt long‑term returns.
Historical earnings and ROE volatility
Past episodes of negative ROE and earnings indicate sensitivity to market cycles and portfolio exposures. This structural volatility reduces predictability of NAV and distributions, complicating multi‑quarter planning and investor return expectations during downturns.
Concentrated exposure to Canadian financials
A concentrated sector focus increases exposure to region‑specific regulatory, credit, or cyclical risk in Canadian financials. As a closed‑end investment vehicle lacking operating diversification, adverse sector moves can materially affect NAV and earnings across several quarters.

Cymbria Corp Cl A (CYB) vs. iShares MSCI Canada ETF (EWC)

Cymbria Corp Cl A Business Overview & Revenue Model

Company DescriptionCymbria Corporation is a closed ended equity fund launched and managed by EdgePoint Investment Group Inc. The fund invests in the public equity markets across the globe. It also invests some portion of its portfolio in derivative instruments, privately held businesses or leverage its investments. The fund holds a substantial amount of investment in EdgePoint Wealth Management. Inc. It invests in the stocks of companies operating across diversified sectors. The fund invests in the value stocks of companies across all market capitalizations. It focuses on factors like proprietary insights, long term views, focus on growth, extensive research, incisive analysis, and assessment of value sums up to create its portfolio. The fund benchmarks the performance of its portfolio against the MSCI World Index (C$). Cymbria Corporation was formed on September 4, 2008 and is domiciled in Canada.
How the Company Makes Moneynull

Cymbria Corp Cl A Financial Statement Overview

Summary
Strong profitability and growth in TTM with very high profit conversion and improved results versus 2024, supported by a conservative balance sheet (very low leverage, healthy ROE). The main drag is cash-flow quality and consistency: operating/free cash flow is far below reported net income in TTM and cash flows have been volatile historically.
Income Statement
84
Very Positive
Profitability is exceptionally strong in TTM (Trailing-Twelve-Months), with very high profit conversion (net income of ~286M on ~311M of revenue) and solid revenue growth (~9.6%). Results also improved versus 2024 (higher revenue and net income). The main weakness is historical volatility: 2020 and 2022 show negative revenue and losses, indicating earnings can be sensitive and not consistently stable across cycles.
Balance Sheet
88
Very Positive
Balance sheet strength is high with low leverage (TTM debt of 50M against equity of ~1.95B; debt-to-equity ~0.03) and a sizable equity base (~1.95B) supporting the asset base (~2.11B). Returns on equity are healthy in TTM (~15.9%) and improved versus 2024. The key watch-out is that performance has swung in prior years (including negative returns on equity in 2020 and 2022), which can pressure capital growth in weaker periods.
Cash Flow
62
Positive
Cash generation is positive in TTM (operating cash flow and free cash flow both ~45.8M) and shows a sharp reported free-cash-flow growth rate. However, cash flow conversion versus earnings looks weak in TTM: operating cash flow (~45.8M) is far below net income (~285.9M), and operating cash flow coverage is much lower than in 2024. History also includes negative operating/free cash flow in 2020 and 2022, highlighting variability in cash generation.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue310.96M241.80M242.79M-88.60M293.32M-17.07M
Gross Profit307.17M238.04M240.27M-90.09M292.93M-17.56M
EBITDA296.12M230.16M233.25M-96.78M286.22M-23.03M
Net Income285.94M200.47M206.21M-80.63M253.57M-13.80M
Balance Sheet
Total Assets2.11B1.85B1.68B1.44B1.52B1.24B
Cash, Cash Equivalents and Short-Term Investments138.33M115.36M138.84M104.53M97.42M47.61M
Total Debt50.00M50.00M50.00M30.05M2.55M6.00M
Total Liabilities162.14M141.06M116.55M73.53M70.74M44.89M
Stockholders Equity1.95B1.70B1.56B1.36B1.45B1.19B
Cash Flow
Free Cash Flow45.75M31.12M24.76M-20.10M53.09M-31.29M
Operating Cash Flow45.75M31.12M24.76M-20.10M53.09M-31.29M
Investing Cash Flow-24.82M0.000.000.000.000.00
Financing Cash Flow-3.20M-57.04M10.37M26.98M-3.47M-1.82M

Cymbria Corp Cl A Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price89.40
Price Trends
50DMA
92.46
Positive
100DMA
88.74
Positive
200DMA
85.10
Positive
Market Momentum
MACD
0.38
Positive
RSI
43.75
Neutral
STOCH
20.01
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CYB, the sentiment is Neutral. The current price of 89.4 is below the 20-day moving average (MA) of 94.81, below the 50-day MA of 92.46, and above the 200-day MA of 85.10, indicating a neutral trend. The MACD of 0.38 indicates Positive momentum. The RSI at 43.75 is Neutral, neither overbought nor oversold. The STOCH value of 20.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:CYB.

Cymbria Corp Cl A Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
C$1.66B5.5313.82%2.29%58.88%82.03%
79
Outperform
C$1.28B7.109.85%3.01%11.23%30.44%
76
Outperform
3.3215.87%52.41%6.05%
74
Outperform
C$825.82M1.289.11%22.33%-25.06%
69
Neutral
C$1.66B5.5313.82%2.29%58.88%82.03%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
54
Neutral
C$617.35M17.0511.26%8.78%-0.88%-52.30%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CYB
Cymbria Corp Cl A
91.79
17.99
24.38%
TSE:AGF.B
AGF Management B NV
18.97
9.36
97.34%
TSE:FSZ
Fiera Capital A
5.62
-0.19
-3.30%
TSE:GCG
Guardian Capital
67.50
28.19
71.72%
TSE:GCG.A
Guardian Cap Cl A NV
67.50
28.46
72.91%
TSE:SEC
Senvest Capital
337.53
-37.23
-9.93%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025